erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. https://oakley-sunglassesformen.us/Baltz-daughter-of-Derouin-from-Hott?Jeskagran=112